GW433908 Expanded Access Program for HIV infected subjects non responding or intolerant to the previous antiretroviral treatments

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-000336-81-IT

Enrollment

1500

Registered

2007-03-06

Start date

2004-07-08

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection MedDRA version: 6.1 Level: PT Classification code 10020161

Interventions

Trade Name: J05AE - Inibitori delle proteasi Product Name: Fosamprenavir Product Code: GW433908 Pharmaceutical Form: Tablet INN or Proposed INN: fosamprenavir Current Sponsor code: GW433908 Concentrat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026